6Braun J,Brandt J,Listing J,et al.Treatment of active ankylosing spondylitis with infliximab:a randomised controlled multicentretrial[J].Lancet,2002,359:1187-1193.
7Schotte H,Schluter B,Willeke P,et al.Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclearcells in patients with rheumatoid arthritis[J].Rheumatology(Oxford),2004,43:960-964.
8Garrett S,Jenkinson T R,Kennedy L G,et al.A new approach to difining disease status in ankylosing spondylistis:the bath AS disease activity indes[J].J Rheumatol,1994,21(12):2-286-2-291.
9Fleischmann RM.Is there a need for new therapies for rheuma-toid arthritis[J].J Rheumatol,2005,73 Suppl:3-7.
10Braun J,Bollow M,Neure L,et al.Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliacjoint biopsy specimens from patients with ankylosing spondylitis[J].Arthritis Rheum,1995,38:499-505.
6Fredriksson T,Pettersson U.sever psoriasis-oral therapy with a new retinoid[J].DermatoIogical,1978,157:238-240.
7Leman J,Burden AD.Sequential use of biologies in the treatment of moderate-to--severe plaque psoriasis [J].Br J Dermatol,2012,167(Suppl 3):12-20.
8Spadaro A,CeccarelIi F,Scrivo R,et al.Life-table analysis of etaner-cept with or without methotrexate in patients with psoriatic arthritis[J].Ann Rheum Dis,2008.67(11):1650-1651.
9Thorlund K,Druyts E,Avina-Zubieta JA,et al.Anti-tumor necrosis factor(TNF)drugs for the treatment of psoriatic arthritis:an indirect comparison meta-analysis[J].Biologies,2012,6:417-427.
10Kimball AB,Pariser D,Yamauchi PS,et al.OBSERVE-5 interim a-nalysis:An observational postmarketing safety registry of etanercept for the treatment of psoriasis[J].J Am Acad Dermatol,2013,(Epub ahead of print).
